In vitro effects of the tyrosine kinase inhibitor, masitinib mesylate, on canine hemangiosarcoma cell lines.
Lyles SE; Milner RJ; Kow K; Salute ME; Veterinary And Comparative Oncology, 2012, vol. 10, issue 3, p 223, ISSN 14765829. ISBN 14765829.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef